Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection
AbstractFew studies have been conducted in the Eastern Mediterranean region on chronic hepatitis C virus [HCV] infection with reference to genotypes. We investigated the response to standard combination therapy [pegylated interferon/ribavirin] of different genotypes of HCV in Kuwaiti patients and factors that could be associated with sustained virological response [SVR]. The records of all Kuwaiti patients treated for chronic HCV between January 2003 and May 2009 were retrospectively identified and reviewed. Of 108 patients studied, 27.8% were infected with genotype 1, 25.0% with genotype 3 and 47.2% with genotype 4. Overall, 64.8% of patients achieved SVR, 25.9%, were non-responders and 9.3% were relapsers. Baseline viral load and alanine aminotransferase level in addition to early virological response to pegylated interferon-based therapy may serve as a decision tool for clinicians to identify patients who are unlikely to achieve SVR
Al Enzi, S.A., Ismail, W.A., Alsurayei, S.A. & Ismail, A.E. (2011). Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection. EMHJ - Eastern Mediterranean Health Journal, 17 (8), 669-678, 2011 https://apps.who.int/iris/handle/10665/118282
JournalEMHJ - Eastern Mediterranean Health Journal, 17 (8), 669-678, 2011
MetadataShow full item record
Showing items related by title and subject
Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients Kishk, R.; Aboul Atta, H.; Ragheb, M.; Kamel, M.; Metwally, L.; Nemr, N. (World Health Organization, Regional Office for the Eastern Mediterranean, 2014)Chronic hepatitis C virus [HCV]infection combined with occult hepatitis B virus [HBV]infection has been associated with increased risk of hepatitis, cirrhosis and hepatocellular carcinoma.This study aimed to determine the ...
John, A.K.; Al Kaabi, S.; John, A.; Singh, R.; Derbala, M. (2010)Hepatitis C virus [HCV] infection is a major public health problem in the Middle East. A database of 400 patients with chronic HCV in Qatar was retrospectively analysed: 242 patients underwent antiviral treatment, of whom ...